 Aim To analyse the potential extra anti-inflammatory effect of extrafine HFA-beclometasone compared to HFA-flucticasone in children with asthma by means of alveolar nitric oxide NO concentration and bronchial NO flux, inflammatory markers in exhaled breath condensate EBC, and conventional parameters. 